| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/10/2007 | CN1293911C Process for preparing medicine for treating headache |
| 01/10/2007 | CN1293909C Granule with ginseng and astragalus root and preparation technique thereof |
| 01/10/2007 | CN1293907C Health product for improving skin moisture content and preparation method thereof |
| 01/10/2007 | CN1293906C Chinese medicine preparation for treating pain caused by stagnation of wind-dampness |
| 01/10/2007 | CN1293903C Asthma-stopping powder injection and its preparation method |
| 01/10/2007 | CN1293902C Oral deodorizing drink |
| 01/10/2007 | CN1293899C Tengdan capsule for treating hypertension |
| 01/10/2007 | CN1293898C Method for preparing pharmaceutical composition for treating viral hepatitis |
| 01/10/2007 | CN1293897C Burn- and scald-treating powder |
| 01/10/2007 | CN1293896C Medication for treating primary thrombocytopenic purpura and preparation method thereof |
| 01/10/2007 | CN1293895C Oral disintegration tablet for treating laryngopathy and its preparing method |
| 01/10/2007 | CN1293893C Gel of Chinese traditional medicine for treating cervicitis, cervical erosion and colpitis and preparation method thereof |
| 01/10/2007 | CN1293891C Oteoporosis-treating medicinal capsule and its preparation method |
| 01/10/2007 | CN1293890C Ointment of Chinese traditional medicine for treating hyperplasia of mammary glands, and preparation method |
| 01/10/2007 | CN1293888C Freeze dried powder injection of dandehon herb and its preparation process |
| 01/10/2007 | CN1293887C Medicine composition for treating cardiovascular and cerebrovascular diseases, and preparation method thereof |
| 01/10/2007 | CN1293880C Aqueous liquid preparations and light-stabilized aqueous liquid preparations |
| 01/10/2007 | CN1293879C Freeze-dried powder injection of pantoprazole sodium and its preparation |
| 01/10/2007 | CN1293878C Preventing or therapeutic agent for eye fatigue and pseudomyopia |
| 01/10/2007 | CN1293874C Traditional Chinese medicine Monascus purpureus went using Lovastatin salt as main active component and its preparation component |
| 01/10/2007 | CN1293872C Oral cavity local administered pharmaceutical composition for treating pharyngitis and preparation method thereof |
| 01/10/2007 | CN1293869C Method and composition for delivering zinc to the nasal membrane |
| 01/10/2007 | CN1293867C Medicinal compound preparation |
| 01/10/2007 | CN1293864C Topical formulations containing ketoprofen stabilised with sulisobenzone |
| 01/10/2007 | CN1293863C Ibolite fumarate nasal cavity administration preparation |
| 01/10/2007 | CN1293856C Reducing agent with several constituents comprising at least a composition in powder form containing a agent for reducing hair sulphur bouds and method for permanent setting of keratin fibres |
| 01/10/2007 | CN1293833C Food coated with sugar |
| 01/09/2007 | US7161012 Processes for preparing amorphous atorvastatin hemi-calcium |
| 01/09/2007 | US7160862 A mixture of polypeptides, as calcium binding protein for reducing bone loss and reducing renal phosphate excretion; biodrug for treating bone disorders; injectable solution or dispersed in toothpaste or a mouthwash or gum patch |
| 01/09/2007 | US7160559 Galantamine hydrobromide particles and a water soluble film forming polymer are layered or coated on inert spheres, covered by a release rate controlling membrane made of a water insoluble polymer and optionally a plasticizer; galantamine and water-soluble polymer topcoat |
| 01/09/2007 | US7160558 Coating and binding agent for pharmaceutical formulations with improved storage stability |
| 01/09/2007 | US7160557 Matrices formed of polymer and hydrophobic compounds for use in drug delivery |
| 01/09/2007 | US7160556 Immediate release medicinal compositions for oral use |
| 01/09/2007 | US7160555 Antidiabetic agents |
| 01/09/2007 | US7160554 Enhanced circulation effector composition and method |
| 01/09/2007 | US7160553 Matrix comprising a polymer network and a non-gellable polysaccharide containing oxygen; may be formed into any desired shape for treatment of compromised tissue or for delivery of oxygen to a localized environment. |
| 01/09/2007 | US7160551 Nonaqueous biocompatible solvent, a biodegradable hydrophobic polymer, and an amphiphilic block copolymer such as ethylene oxide-propylene oxide triblock copolymer; use as an injectable implant; no initial "burst" |
| 01/09/2007 | US7160544 Method of vaccinating vertebrates |
| 01/09/2007 | US7160538 Employing 1,1,1,2,3,3,3-heptafluoropropane as the sole propellant gas for administration of micronized or powdered drugs by inhalation |
| 01/09/2007 | US7160536 Radiolabelled metal transport proteins as imaging agents |
| 01/09/2007 | US7160284 Implantable medical pump with multi-layer back-up memory |
| 01/09/2007 | CA2467490C Pharmaceutical compositions of 5,8,14-triazatetracyclo[10.3.1.0(2,11).0(4,9)]-hexadeca-2(11)3,5,7,9-pentaene |
| 01/09/2007 | CA2371917C After shave composition containing aluminum chlorohydrate |
| 01/09/2007 | CA2343376C Sustained release ranolazine formulations |
| 01/09/2007 | CA2340056C Pharmaceutical compositions containing lipase inhibitors |
| 01/09/2007 | CA2335030C Medical infusion device with a source of controlled compliance |
| 01/09/2007 | CA2333427C Foaming composition for hair care |
| 01/09/2007 | CA2308520C Strictly alternating poly(alkylene oxide ether) copolymers |
| 01/09/2007 | CA2301165C In situ formation of polymeric material |
| 01/09/2007 | CA2295177C Drug targeting system, method of its preparation and its use |
| 01/09/2007 | CA2294172C Pharmaceutical composition in form of solid lipidic microparticles suitable to parenteral administration |
| 01/09/2007 | CA2294033C Pharmaceutical composition for acidic lipophilic compounds in a form of a self-emulsifying formulation |
| 01/09/2007 | CA2271167C Device and method for enhancing transdermal agent flux |
| 01/09/2007 | CA2251702C Biologically active composition |
| 01/09/2007 | CA2251564C Buccal, non-polar spray for nitroglycerin |
| 01/09/2007 | CA2237554C A method and apparatus for producing liposomal parenteral medicaments via high pressure homogenization |
| 01/09/2007 | CA2210985C Pharmaceutical composition containing fenofibrate and polyglycolized glycerides |
| 01/09/2007 | CA2202103C Method for preparing closed vesicles |
| 01/09/2007 | CA2184262C Hygienic and cosmetic preparations for preventing and treating skin-diseases as well as a process for obtaining same |
| 01/09/2007 | CA2142126C Inhalation powder containing antistatic agent |
| 01/04/2007 | WO2007002906A1 Methods and dosage forms for reducing side effects of carbamate compounds |
| 01/04/2007 | WO2007002886A2 Compositions and methods for less immunogenic pr0tein-lip1d complexes |
| 01/04/2007 | WO2007002823A2 Formulations of conjugated estrogens and bazedoxifene |
| 01/04/2007 | WO2007002780A2 Topical preservative compositions |
| 01/04/2007 | WO2007002761A2 Micogel topical formulations |
| 01/04/2007 | WO2007002709A2 Complexation of metal ions with polypeptides |
| 01/04/2007 | WO2007002523A2 Collapsible patch with microneedle array |
| 01/04/2007 | WO2007002518A1 Delayed release or extended-delayed release dosage forms of pramipexole |
| 01/04/2007 | WO2007002516A2 Improved dosage forms for movement disorder treatment |
| 01/04/2007 | WO2007002362A2 A direct drug delivery system based on thermally responsive biopolymers |
| 01/04/2007 | WO2007002345A2 Method for improving water solubility of chitosan |
| 01/04/2007 | WO2007002318A2 Bioadhesive polymers |
| 01/04/2007 | WO2007002238A2 Drug/polymer composite materials and methods of making the same |
| 01/04/2007 | WO2007002186A1 Dronabinol treatment for migraines |
| 01/04/2007 | WO2007002125A1 Rapidly absorbing oral formulations of pde5 inhibitors |
| 01/04/2007 | WO2007002041A2 Drug-filled polymer films |
| 01/04/2007 | WO2007001957A1 Water soluble analgesic formulations and methods for production |
| 01/04/2007 | WO2007001926A2 Low-swelling hydrogel sealants for wound repair |
| 01/04/2007 | WO2007001891A1 Transdermal delivery of cannabinoids |
| 01/04/2007 | WO2007001888A2 New regimens for controlled drug delivery devices for contraception |
| 01/04/2007 | WO2007001451A2 Stabilized hme composition with small drug particles |
| 01/04/2007 | WO2007001448A2 Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals |
| 01/04/2007 | WO2007001356A2 Nanoparticles for cytoplasmic drug delivery to cancer cells |
| 01/04/2007 | WO2007001185A1 Drink comprising a combination of fish oil and probiotics |
| 01/04/2007 | WO2007001086A1 Orally disintegrating powder comprising cilostazol and mannitol |
| 01/04/2007 | WO2007001067A2 Solid dosage form comprising an angiotensin ii receptor antagonist and a calcium channel blocker |
| 01/04/2007 | WO2007001065A2 Method for the preparation of a wet granulated drug product |
| 01/04/2007 | WO2007000939A1 Therapeutic agent for local inflammation |
| 01/04/2007 | WO2007000842A1 Granule dispersion composition, process for producing the same, and granular material and medicine |
| 01/04/2007 | WO2007000779A2 Pharmaceutical sustained release compositions and processes thereof |
| 01/04/2007 | WO2007000778A2 Modified release pharmaceutical compositions on the basis of two polymers and processes thereof |
| 01/04/2007 | WO2007000764A2 Compositions and methods for enhancement of sexual function |
| 01/04/2007 | WO2007000192A1 Topical compositions comprising nanoparticles of an isoflavone |
| 01/04/2007 | WO2007000038A1 Medicated gumstick for treatment in anti-inflammatory conditions and prophylaxis against nsaid gastropathy |
| 01/04/2007 | WO2006124506A3 Combination and use of drugs |
| 01/04/2007 | WO2006120696A3 An improved pharmaceutical composition |
| 01/04/2007 | WO2006106521A3 Hydrophilic dispersions of nanoparticles of inclusion complexes of macromolecules |
| 01/04/2007 | WO2006094782A3 Composition for oral application with controlled release of active substances |
| 01/04/2007 | WO2006094736A3 Alfuzosin controlled-release formulations |
| 01/04/2007 | WO2006065141A3 Method and device for manufacturing products comprising medication |